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Abstract: Unimolecular polymeric micelles are a class of single-molecule amphiphilic core-shell
polymeric architectures, where the hydrophobic core is well stabilized by the hydrophilic shell,
avoiding intermolecular core-core interactions. Multi-arm copolymers with a dendritic core, as well
as hyperbranched and comb-like polymers, can form unimolecular micelles easily. In this review,
examples of polymers able to form detectable unimolecular micelles will be presented, summarizing
the analytical techniques used to characterize the unimolecular micelles and discriminate them
from other supramolecular aggregates, such as multi-micelle aggregates. Unimolecular micelles
are suitable for the nanoencapsulation of guest molecules. Compared to traditional supramolecular
micelles, unimolecular micelles do not disassemble under dilution and are stable to environmental
modifications. Recent examples of their application as drug delivery systems, endowed with increased
stability and transport properties, will be discussed.
Keywords: complex polymeric architectures; unimolecular micelles; unimolecular micelles characterization;
drug delivery; nanoencapsulation
1. Introduction
Unimolecular polymeric micelles are a class of single-molecule micelles having a core and a shell
with two different polarities and covalently linked together [1–3]. Nano-sized unimolecular polymeric
micelles are formed once appropriate amphiphilic polymeric molecules are dispersed in a selective
solvent, i.e., a good solvent for the block with one polarity and precipitant for the block with the
opposite polarity. In an aqueous solution, the hydrophobic polymeric core is efficiently wrapped and
stabilized by the hydrophilic shell, avoiding core-core intermolecular interactions (Figure 1a) [4,5].
Differently from conventional polymeric micelles, which are thermodynamic aggregates of amphiphilic
polymers above a certain concentration threshold, known as Critical Micelle Concentration (CMC) [6]
(Figure 1b,c), unimolecular polymeric micelles are stable upon high dilutions, and could be formed
below typically expected CMC values for the hydrophilic/lipophilic balance of the amphiphilic
polymer [7].
Many polymeric amphiphilic species, having different topologies, can form unimolecular micelles.
They are generally multi-arm polymers, where hydrophilic chains emanate from a central dendrimeric,
hyperbranched or simply multivalent core [8]. It is known that increasing the complexity and the
hindrance of polymeric structures, as well as the number of soluble branches, the formation of large
micellar structures is less favored [9].
Pharmaceutics 2018, 10, 209; doi:10.3390/pharmaceutics10040209 www.mdpi.com/journal/pharmaceutics
Pharmaceutics 2018, 10, 209 2 of 19
Pharmaceutics 2018, 10, x FOR PEER REVIEW  2 of 19 
Pharmaceutics 2018, 10, x; doi: FOR PEER REVIEW  www.mdpi.com/journal/pharmaceutics
 
Figure 1. (a) Unimolecular micelles in aqueous solution are single‐molecule architectures constituted 
by a hydrophobic core (black) and a hydrophilic shell (dashed red) covalently linked to a backbone 
(green); (b) conventional polymeric micelles in aqueous solution are an aggregation of amphiphiles 
having hydrophobic (black) and hydrophilic (dashed red) moieties; and (c) at a concentration below 
Critical Micelle Concentration (CMC), conventional micelles disassemble into free polymeric chains. 
Many polymeric amphiphilic species, having different topologies, can form unimolecular 
micelles. They are generally multi‐arm polymers, where hydrophilic chains emanate from a central 
dendrimeric, hyperbranched or simply multivalent core [8]. It is known that increasing the 
complexity and the hindrance of polymeric structures, as well as the number of soluble branches, the 
formation of large micellar structures is less favored [9].  
The preparation of polymers able to form unimolecular micelles and their application as 
functional materials have recently been reviewed [1]; nevertheless, to the best of our knowledge, a 
systematic summary of the methods used to dissect their self‐assembling behavior is missing. This 
would be beneficial to unambiguously assess the presence of unimolecular micelles or aggregates of 
unimolecular micelles, or the coexistence of more than one species. It is indeed possible that 
unimolecular micelles self‐assemble in a kind of multi‐micelle aggregates, characterized by an 
entanglement of the hydrophilic branches (Figure 2a), and/or they rearrange forming primary 
micelles, where the hydrophilic arms stabilize an aggregate of hydrophobic cores (Figure 2b) [10]. 
With this review, we aim to provide an overview of the techniques that have been employed to detect 
and characterize unimolecular micelles. 
 
Figure 2. Unimolecular micelles can self‐assemble forming (a) multi‐micelle aggregates and/or (b) 
primary micelles. 
One of the main advantages of unimolecular micelles compared to the conventional ones 
concerns their application as drug delivery systems [11–13]. Indeed, amphiphilic polymers can self‐
assemble in aqueous solutions accommodating guest molecules within their core. This ability is 
exploited to encapsulate hydrophobic drugs, thus improving their solubility and their circulation 
time in the blood, protecting them from the surrounding environment and non‐specific uptake by 
the mononuclear phagocyte system [14]. Conventional micelles subjected to high dilutions in the 
bloodstream might disassemble [15], leading to burst release of the encapsulated drug, possible toxic 
effects related to high variations of local drug concentration, and finally the inability to reach the 
Figure 1. (a) Unimolecular micel es i l tion are single-molecule architectures constituted
by a hydrophobic ore (black) and a hy r ll ( ashed red) covalently linked to a backbone
(green); (b) conventional polymeric ic ll s i s solution are an a gregation of amphiphiles
having hydrophobic (black) and hydro ilic ( as e red) oieties; and (c) at a concentration below
Critical Micelle Concentration (CMC), conventional icelles disassemble into free polymeric chains.
The preparation of polymers able to form unimolecular micelles and their applicatio as functional
materials have recently been reviewed [1]; nevertheless, to the best of our knowledge, a systematic
summary of the methods used to dissect their self-assembling behavior is missing. This would be
beneficial to unambiguously assess the presence of unimolecular micelles or aggregates of unimolecular
micelles, or the coexistence of more than one species. It is indeed possible that unimolecular micelles
self-assemble in a kind of multi-micelle aggregates, characterized by an entanglement of the hydrophilic
branches (Figure 2a), and/or they rearrange forming primary micelles, where the hydrophilic arms
stabilize an aggregate of hydrophobic cores (Figure 2b) [10]. With this review, we aim to provide an
overview of the techniques that have been employed to detect and characterize unimolecular micelles.
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Figure 2. Unimolecular micelles can self-assemble forming (a) multi-micelle aggregates and/or
(b) primary micelles.
One of the main advantages of unimolecular micelles compared to the conventional ones concerns
their application as drug delivery systems [11–13]. Indeed, amphiphilic polymers can self-assemble
in aqueous solutions a com odating guest molecules within the r core. This ability is exploited to
encapsulate hydrophobic drugs, thus improving their solubility and their circulation time in the blood,
protecting them from the surrounding environment and non-specific uptake by the mononuclear
phagocyte system [14]. Conventional micelles subjected to high dilutions in the bloodstream might
disassemble [15], leading to burst release of the encapsulated drug, possible toxic effects related to
high variations of local drug concentration, and finally the inability to reach the targeted site. In this
review, recent examples of thermodynamically stable unimolecular micelles used to transport poorly
solubl hydrophobic drugs to targeted organs/tissues will also be presente .
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2. Preparation of Unimolecular Micelles
In order to prepare unimolecular polymeric micelles in aqueous solution, a dense hydrophilic
shell, able to stabilize the core, is needed. As a matter of example, highly branched macromolecules,
including multi-arm and hyperbranched polymers, are commonly stabile and non-entangling [4].
Tailoring the structure of polymeric molecules is therefore essential. Moreover, polymers compositions
and final molecular weights affect the size of resulting micellar structures, and therefore the scope of
their applications. In recent reviews, various types of amphiphilic polymers with complex architectures
that have been applied in the fabrication of unimolecular micelles have been reported [1,16].
Amphiphilic dendrimers, hyperbranched polymers, star polymers, other types of amphiphilic
polymers (bottlebrush [17,18], Y shaped [19,20], and cyclic [21,22]) have been designed for this purpose.
Controlled polymerization techniques (such as Ring Opening Polymerization (ROP) and Atom Transfer
Radical Polymerization (ATRP)), which allow a good control over the structure, the molecular weight
and the polydispersity of the synthesized macromolecules [23], are generally exploited, often in
combination with “grafting through”, “grafting onto”, or “grafting from” approaches to obtain
amphiphilic graft copolymers [1]. Examples of multi-arm and hyperbranched polymers, characterized
by a complex and controlled architecture and able to form detectable and able to be characterized
unimolecular micelles, will be presented hereafter.
2.1. Multi-Arm Polymers
Unimolecular micelles can be obtained from a variety of different multi-arm polymers. Multi-arm
star amphiphilic block copolymers built on hydrophobic H40, a fourth generation dendrimeric polyester
(Boltorn-type), have been reported [24–26]. Polymers can be synthesized either initiating the ROP of
lactones with H40-OH and finally coupling the resulting polyesters with hydrophilic poly(ethylene
glycol) (PEG) chains, or coupling amphiphilic polyester-PEG chains onto H40 via ester linkage.
Multi-arm polymers with an aromatic dendritic polyphenylene core were reported by
Yin et al. [27]. The shell of poly(2-aminoethyl) repeating units was obtained by ATRP of N-2-[(tert-
butoxycarbonyl)amino] ethyl methacrylate (Boc-AEMA), followed by Boc deprotection. Gong and
coworkers built a multi-arm star amphiphilic block copolymer starting from a polyamidoamine
(PAMAM) dendrimeric core [28]. PAMAM-OH (generation four) served as the macroinitiator for
the ROP of valerolactone. The resulting hydrophobic segments were then activated and pegylated.
Final polymer PAMAM-PVL-PEG-KE108/Cy5, able to form unimolecular micelles in water (Figure 3),
was obtained after a further functionalization with a targeting peptide (KE108) and a dye (Cy5).
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A trivalent aromatic scaffold, 1,1,1-tris(4’-hydroxyphenyl)ethane, was used by the group of Uhric
to synthesize a multi-arm polymer with a pegylated hydrophilic shell and an inner hydrophobic core
constituted by mucic acid functionalized with several fatty acids (e.g., hexanoyl chloride, Figu e 4) [29].
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Figure 4. Multi‐arm polymers based on a poly‐alkylated hydrophobic core and a pegylated 
hydrophilic shell. Reproduced with permission from reference [29], Royal Society of Chemistry, 2000. 
The group of Schubert reported the formation of unimolecular micelles from amphiphilic multi‐
arm comb‐like polymers. Pentaerythritol or dipentaerythritol initiated the ROP of ε‐caprolactone 
(CL); resulting polyester chains were then converted into 2‐bromoisobutyryl derivatives and used as 
macroinitiators of the ATRP of poly(ethylene glycol) methyl ether methacrylate (PEGMA). By 
varying the number of CL and PEGMA repeating units, a library of polymers with the general 
structure described in Figure 5 was obtained [30]. In another study, these polymer architectures were 
used to generate steroid‐loaded ultrasmall nanocarriers for targeted delivery to the kidney 
glomerulus [31]. 
 
Figure 5. Amphiphilic multi‐arm star‐shaped block copolymers based on a poly(ε‐caprolactone) core 
and a pegylated comb‐like shell. Reproduced with permission from reference [30], Royal Society of 
Chemistry, 2009. 
2.2. Hyperbranched Polymers 
Hyperbranched polymers have been widely used for unimolecular micelle preparation. In 
contrast to the multi‐step synthesis of precisely defined dendrimers, hyperbranched macromolecules 
can be synthesized in much easier approaches, which are often based on convenient one‐step 
syntheses [1]. 
Amphiphilic hyperbranched polymers can be synthesized by functionalizing polyglycerol. The 
group of Haag generated unimolecular micelles (Rh ≤ 5 nm, AFM) by selectively functionalizing the 
terminal hydroxyl groups of hyperbranched polyglycerol (Mn = 21,000 Da) with long alkyl chains 
(C15, C16). pH‐responsive nanocarriers, able to encapsulate polar guest molecules, were obtained by 
using acetals/ketals acid‐sensitive linkages (Figure 6). The shell cleavage under acidic conditions 
4. Multi-arm polymers based on a poly-alkylated hydrophobic core and a p gylated hydrophilic
shell. Reproduced with permission from reference [29], Royal Society of Chemistry, 2000.
The group of Schubert reported the formation of unimolecular micelles from amphiphilic
multi-arm comb-like polymers. Pentaerythritol or dipentaerythritol initiated the ROP of ε-caprolactone
( L); resulting polyester chains ere then converted into 2-bro oisobutyryl derivatives and used as
acroinitiators of the ATRP of poly(ethylene glycol) methyl ether methacrylate (PEGMA). By varying
the number of CL and PEGMA repeating units, a library of polymers with the general structure
described in Figure 5 was obtained [30]. In another study, these polymer architectures were used to
generate steroid-loaded ultrasmall nanocarriers for targeted delivery to the kidney glomerulus [31].
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2.2. Hyperbranched Polymers
Hyperbranched polymers have been widely used for unimolecular micelle preparation. In contrast
to the multi-step synthesis of precisely defined dendrimers, hyperbranched macromolecules can be
synthesized in much easier approaches, which are often based on convenient one-step syntheses [1].
Amphiphilic hyperbranched polymers can be synthesized by functionalizing polyglycerol.
The group of Haag generated unimolecular micelles (Rh ≤ 5 nm, AFM) by selectively functionalizing
the terminal hydroxyl groups of hyperbranched polyglycerol (Mn = 21,000 Da) with long alkyl chains
(C15, C16). pH-responsive nanocarriers, able to encapsulate polar guest molecules, were obtained by
using acetals/ketals acid-sensitive linkages (Figure 6). The shell cleavage under acidic conditions
resulted in cargo release [32]. By using a similar synthetic approach, reverse unimolecular micelles
were also obtained in cyclohexane from hyperbranched polyglycerols, whose hydroxyl groups were
parti lly functionalized with palmitoyl chloride [33].
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partially functionalized with palmitoyl chloride [33]. 
 
Figure 6. A hydrophilic hyperbranched polyglycerol, whose vicinal hydroxyl groups were partially 
functionalized as acetals or ketals by reacting with aldehydes or ketons with long alkyl chains. 
Reproduced with permission from reference [32], Wiley, 2002. 
Qui et al. obtained pH‐ and redox‐responsive unimolecular micelles from camptothecin (CPT)‐
conjugated hyperbranched star copolymers containing acid‐labile β‐thiopropionate linkage [34]. 
These HP(HPMA‐co‐MACPT‐co‐BS2MOE)(POEGMA)n copolymers (Figure 7) were characterized by 
hyperbranched macroinitiators functionalized with hydrophilic poly‐oligo(ethylene glycol) 
(POEGMA). Macroinitiators were obtained by ATRP of hydroxypropyl methacrylate (HPMA), 
methacryloyloxy‐3‐thiohexanoyl‐camptothecin (MACPT), and 2‐(2′‐bromoisobutyryloxy)ethyl‐2″‐
methacryloyl oxyethyl disulfide (BS2MOE), which acted as the inimer (i.e., the branching agent being 
simultaneously the initiator and the propagating species) [34]. The obtained polymers formed 
unimolecular micelles in water, and their release of CPT at various pHs as well as their anticancer 
efficacy was confirmed in vitro. 
 
Figure 7. Hyperbranched amphiphilic star copolymers with a HPMA‐co‐MACPT‐co‐BS2MOE core 
and a POEGMA (red) hydrophilic shell. Reproduced with permission from reference [34], Royal 
Society of Chemistry, 2016. 
Amphiphilic hyperbranched fluoropolymers were proposed as nanoscopic 19F Magnetic 
Resonance Imaging Agents [35]. Atom transfer radical self‐condensing vinyl (co)polymerization 
(ATR‐SCVCP) of 4‐chloromethyl styrene in the presence of lauryl acrylate, initiated by 1,1,1‐tris(4′‐
(2′′‐bromoisobutyryloxy)phenyl)ethane (TBBPE), yielded the hydrophobic core of a hyperbrached 
polymer, finally obtained by subsequent polymerization of trifluoroethyl methacrylate (TFEMA) and 
tert‐butylacrylate. The fluorinated amphiphilic polymers were obtained after restoring the acidic 
functionality of the acrylic acid, and they formed unimolecular micelles in water [35]. 
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Qui et al. obtained pH- and redox-responsive unimolecular micelles from camptothecin
(CPT)-conjugated hyperbranched star copolymers containing acid-labile β-thiopropionate linkage [34].
These HP(HPMA-co-MACPT-co-BS2MOE)(POEGMA)n copolymers (Figure 7) were characterized by
hyperbranched macroinitiators functionalized with hydrophilic poly-oligo(ethylene glycol) (POEGMA).
Macroinitiators were obtained by ATRP of hydroxypropyl methacrylate (HPMA), methacryloyloxy-3-
thiohexanoyl-camptothecin (MACPT), and 2-(2′-bromoisobutyryloxy)ethyl-2′′-methacryloyl oxyethyl
disulfide (BS2MOE), which acted as the inimer (i.e., the branching agent being simultaneously the
initiator and the propagating species) [34]. The obtained polymers formed unimolecular micelles
in water, and their release of CPT at various pHs as well as their anticancer efficacy was confirmed
in vitro.
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Amphiphilic hyperbranched fluoropolymers were proposed as nanoscopic 19F Magnetic
Resonance Imaging Agents [35]. Atom transfer radical self-condensing vinyl (co)polymerization
(ATR-SCVCP) of 4-chloromethyl styrene in the presence of lauryl acrylate, initiated by 1,1,1-tris(4′-
(2′ ′-bromoisobutyryloxy)phenyl)ethane (TBBPE), yielded the hydrophobic core of a hyperbrached
polymer, finally obtained by subsequent polymerization of trifluoroethyl methacrylate (TFEMA) and
tert-butylacrylate. The fluorinated amphiphilic polymers were obtained after restoring the acidic
functionality of the acrylic acid, and they formed unimolecular micelles in water [35].
3. Characterization Methods
3.1. Characterization of Unimolecular Micelles
One of the most common methods used to assess the presence of unimolecular micelles in solution
is used to compare their size with the size of the coils of a single polymeric molecule in solution
(predicted or experimentally determined). The size of unimolecular micelles is often determined by
means of Dynamic Light Scattering (DLS) analysis [36]. For instance, the hydrodynamic diameter Dh
of micelles formed by HP(HPMA-co-MACPT-co-BS2MOE)(POEGMA)n polymers (Figure 7) [34] in
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water varied from 3.5 to 6.3 nm, increasing as a function of polymers molecular weight. Dh values
were in line with the size of isolated polymeric molecules, estimated with the length of chemical bonds.
Haag et al. predicted the size of a hyperbranched polyglycerol with Mn = 21,000 Da (Figure 6)
according to force-field calculations and mass-volume correlations [32].
In several examples, the average size values measured by DLS are compared with data obtained
by Transmission Electron Microscopy (TEM) [24,25,35,37,38]. The DLS analyses of PAMAM-PVL-
PEG-KE108/Cy5 micelles [28] showed a mean Dh of 56 nm, in line with the size determined by TEM
microscopy (Dh = 38 nm), which disclosed spherical nanoparticles with a clear core-shell structure.
Generally, diameters measured by DLS are slightly higher than those measured by TEM, because
in the first case micelles are in an aqueous solution, where hydrophilic components swell and extend,
whilst in the second case, they are dried [24,36].
In case of bottlebrush micelles, small-angle X-ray and neutron scattering (SAXS, SANS) can also
be used to examine micelle morphology and internal structure, and to obtain information regarding
the overall size of the polymer and cross-sectional dimensions, thus evaluating the intermolecular
assembly and possible formation of large aggregates [39,40].
In many reports micelle size in water or another selective solvent, obtained by DLS, is
compared with the size that they have in a non-selective solvent, where they are soluble, isolated
and not prone to form aggregates. As an example, the size in aqueous buffer (selective solvent)
of poly(phenylene)-star-poly(aminoethyl methacrylate) was comparable with the one of their
Boc-precursors in dichloromethane (non-selective solvent) [27]. Moreover, the value of hydrodynamic
radius calculated at different scattering angles did not change, and this corroborated the existence of
isolated and well-defined species [41]. Star-shaped PCLp(mPEGMA)s, depicted in Figure 5, had a
similar size in water or THF, slightly higher in water, likely because of the PEGMA shell swelling [10].
In contrast to conventional micelles, unimolecular polymeric micelles do not form according to
a CMC transition. There are several experimental methods that can be used to assess this behavior.
Uhric et al. showed that the surface tension profile of the polymers in Figure 4, dissolved in aqueous
solution at a concentration ranging from 10−4 to 10−6 M (corresponding to ~2–0.02 mg/mL), did
not have a distinct change of slope [29]. The lack of CMC was considered as the proof of the
lack of intermolecular polymeric aggregations. Following an analogous procedure, concentration
dependent DLS analyses were performed on PCLp(mPEGMA)s comb-like polymers (Figure 5) [10].
As expected, the derived count rate increased as a function of concentration, but never showed a sudden
change, which would have been attributed to a transition from unimolecular micelles to multi-micelle
aggregates. Plotting the number of scattered photons determined by light scattering analysis vs.
concentration is another way to calculate CMC values [42]. The constancy of the hydrodynamic radius
itself with respect to concentration can corroborate the lack of aggregating behaviors [33].
Fluorescent probes can also be used to determine critical micelle concentration values; pyrene
is probably the most exploited one. It is an aromatic dye having a low water solubility (<1 mg/L)
and a different fluorescent behavior according to the polarity of the medium [43]. In the presence
of amphiphiles, a rapid change of the ratio of the pyrene emission bands I370 to III390 indicates the
transition from single molecules to micelles, able to solubilize the dye in their hydrophobic core [44].
It could also indicate a transition from unimolecular micelles to multi-micelle aggregates, if the first
ones are unable to encapsulate pyrene molecules. Oil Red O or Nile Red can also be used for this
purpose; a fluorescent emission signal is detected only when they are solubilized in the medium,
namely, they are encapsulated in a hydrophobic domain. It has been observed that some amphiphilic
polymeric species showing a CMC with the pyrene assay lacked a CMC when using Oil Red O or
Nile Red dyes [10,45]. Schubert and coworkers claimed that pyrene assay is not always reliable, since
the change of the ratio of band I to band III can be affected by the dye excimer formation if the dye
concentration exceeds the polymer encapsulation capacity [10]. At the same time, a transition from
unimolecular to multimolecular micelles might not be detected by those dyes that can be solubilized
by both of the species. Since the dyes activity varies according to their polarity and their affinity
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for the micellar cores, which might be difficult to be predicted a priori, a comparison of different
analytical techniques would be recommended to get a more reliable picture of the micelles real
morphological behavior.
3.2. Characterization of Multi-Micelle Aggregates
The formation of unimolecular micelles and their coexistence with larger associated micelles has
been reported in several papers [38,46].
Hong et al. synthesized multi-arm polymers with a hyperbranched poly(3-ethyl-3-
(hydroxymethyl)oxetane) (HBPO) core and a shell constituted by many poly(2-(dimethylamino)ethyl
methacrylate) (PDMAEMA) chains [47]. The presence of two distinct species in water, having a Dh of
about 10 and 100 nm, respectively, was assessed by both DLS and TEM analyses. The smallest species
were considered the unimolecular micelles, since their sizes were comparable with the length of the
PDMAEMA chain (i.e., 18 nm, if it adopted a completely zig–zag stretched conformation). As clearly
shown by TEM images, the hundred-nanometer-sized species were multi-micelle aggregates built up
from the aggregation of unimolecular micelles. The coexistence of the two species was observed at
10 mg/mL, far above their CMC, which was 0.02–0.05 mg/mL (measured with both the pyrene and
the Nile Red dyes). Below this concentration value, only unimolecular micelles likely exist.
The group of Haag reported a multi-shell complex polymer constituted by a hydrophilic dendritic
poly(ethylene imine) (PEI) core, a nonpolar inner shell formed by alkyl diacids (C6, C12, or C18) and,
finally, a polar pegylated outer shell [48]. The Dh of unimolecular molecules in water was predicted
to be approximately 6 nm by molecular modeling, and a CMC of 0.1 mg/mL was calculated by
surface tension analysis. Additionally, in this case, DLS and TEM analyses in water, performed at a
concentration of 0.5–10 mg/mL and 1 mg/mL, respectively, showed the coexistence of unimers
(Dh ~5 nm) and aggregates (Dh ~30–50 nm) formed by a large number of unimolecular species.
Authors attributed the self-assembly process to the aliphatic chains, and the additional stabilization of
the aggregates to the polyethylene glycol chains.
Similarly, a multi-arm polymer HCP-N-PEG, synthesized by pegylating an hyperbranched
conjugated polymer (HCP) based on tri-substituted benzene and N-alkylated carbazole moieties,
yielded unimolecular and multimolecular micelles in water [49,50]. The two species were
simultaneously detected by means of DLS and TEM analyses. Interestingly, the core molecules
are fluorescent, and a new emission peak appears when they collapse together. The lack of this new
peak in the fluorescent spectrum of HCP-N-PEG micelles in aqueous solution demonstrated that
big aggregates are formed by the self-assembly of unimolecular micelles and not by intermolecular
aggregation of HCP cores [51].
A multi-arm amphiphilic block copolymer, based on a PAMAM-OH (generation 2) core,
functionalized with poly(ε-caprolactone)-polyethylene glycol (PCL-PEG) copolymers, formed both
unimolecular and aggregated micelles in water, with a CMC of 3 mg/mL (pyrene test) [45]. The two
species, with a Dh of 16.9 nm and a 75 nm, respectively, according to DLS analyses (12 mg/mL), were
detected also by size exclusion chromatography in aqueous solution. Aggregates might result from
hydrophobic-hydrophobic interactions or van der Waals interactions between the exposed hydrophobic
PCL cores of the single polymeric molecules. Remarkably, no CMC value was detected using Oil
Red O (ORO) as fluorescent dye; this was probably due to the fact that ORO, being more polar than
pyrene, has a higher compatibility with the core of unimolecular micelles, which is expected to be less
hydrophobic than the one of micelle aggregates.
4. Unimolecular Micelles as Drug Delivery Systems
As complex polymeric architectures may self-assemble forming stable unimolecular micelles, they
can encapsulate and transport poorly soluble hydrophobic drugs, enhancing the therapeutic efficacy
and reducing the side effects in vivo [52].
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Nowadays, most of the nanocarrier systems used in nanomedicine are designed for anticancer
therapies, which often relies on the so-called Enhanced Permeability and Retention effect (EPR) to
passively target and reach tumors [53]. On the other hand, active targeting can be performed by
functionalizing nanoparticles surface with molecules (e.g., peptides, antibodies) specifically recognized
by tumor or other targeted cells [54].
In this section, recent examples of unimolecular micelles for drug delivery will be presented,
especially highlighting the in vivo applications.
4.1. Drug Loading and Release
The drug loading is generally achieved by solvent evaporation or dialysis methods, as developed
for standard polymer micellar systems [55,56]. Typically, the drug and the polymer are dissolved in an
organic solvent where the two compounds are both miscible [57]. Water or buffer is added directly
to the solution to cause micelle formation, then the organic solvent (e.g., acetone, THF, acetonitrile)
is removed by nitrogen flux or vacuum evaporation, and the encapsulation of the drug is finally
obtained. When the solvent is not easily removable by evaporation (such as DMF, DMSO), a dialysis
can be used. Alternatively, the organic polymer-drug solution is dried and the resulting matrix is
hydrated afterwards by H2O or buffers (PBS) to obtain drug-loaded micelles [58]. The characterization
of drug-loaded micelles is similar to other nanoparticles. Parameters of interest are the drug loading
(DL) and the drug encapsulation efficiency (EE), which are defined as DL = WL/WN and EE = WL/W0,
where WL is the weight of loaded drug, WN the weight of the nanoparticle, and W0 the quantity of
drug initially added in the formulation. The typical drug loading DL is in the range 1–20 wt% for
unconjugated drugs.
The in vitro release studies are generally carried out by transferring the drug-loaded micelles into
dialysis membrane tubing (at a molecular weight cut-off below the polymer average molecular weight)
in containers filled with buffers which are maintained at physiological pH and temperature [50,59].
The tests are carried out under sink conditions [15,50], i.e., the total volume of the release medium
is chosen so that when drug is completely released the concentration is below its solubility [59].
The amount of drug released at different time-points is usually quantified by HPLC or fluorescence.
In general, the release profiles are characterized by a rapid-release phase followed by a slower
sustained-release phase, and they are affected by the drug-polymer interactions and by the drug
solubility in the medium [15,50,59].
4.2. Biocompatibility
In drug delivery, it is crucial to evaluate the factors that affect the biocompatibility of the
nanocarriers, in order to ensure safe drug release. Biocompatibility of unimolecular micelles is generally
achieved when they interacts with the host without inducing unacceptable toxic, immunogenic,
thrombogenic, and carcinogenic responses, as in the case of any type of polymeric nanoparticles [60].
These responses are typically dependent on polymer composition and biodegradability, particle size,
and surface properties [61]. Complex polymeric architectures based on a biodegradable polyester and
PEG blocks usually guarantee low cytotoxicity, minimize long term in vivo accumulation, and limited
activation of the mononuclear phagocyte system (MPS). In fact, polymers such as PLA, PCL, and PEG
are considered adequately biocompatible by the regulatory agencies such as the US Food and Drug
Administration (FDA) and the European Medicines Agency (EMEA) [60,61].
However, metal catalysts are commonly used in controlled polymerizations such as ROP and
ATRP, and some studies have pointed out their toxicity for human health, as they tend to accumulate
in the body, where they interact with enzymes and other biomolecules, and are involved with redox
reactions [62,63]. Since the removal of metal impurities from synthetic polymers is generally expensive,
organocatalysts have been used for the preparation of FDA-approved polyesters [62]. “Green” ATRP
strategies have also been proposed as an alternative to traditional ATRP, which needs a relatively large
amount of copper catalyst (typically of the order of 0.1–1 mol% relative to monomer) [63]. For instance,
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the copper amount can be highly reduced by using activators generated by electron transfer (AGET)
ATRP [62]. Alternatively, it can be substituted by a more biologically friendly iron catalyst [64].
While polyesters are hydrolyzable in a biological environment, the unimolecular micelles
may also contain non-biodegradable polymer sequences (PEG blocks, vinyl (carbon-carbon)
backbones, non-degradable multifunctional cores). Therefore, the complex macromolecules should
be metabolized/degraded to yield low-molecular-weight compounds or macromolecular products
with molecular weight lower than 10–50 kDa, which can be finally excreted by the kidneys [65,66].
Non-degradable polymers that are too large to undergo renal clearance may be retained in the body
for an extended period of time, with possible long-term nanotoxic effects [67].
Due to the high complexity of the chemical and physical phenomena, which are involved in
the nanocarrier-host interactions, the biocompatibility of unimolecular micelles should be tested on
a case-by-case basis. Cytotoxicity tests (such as MTT assay or similar), as well as the evaluation of
the effect of the nanomaterial on intracellular reactive oxygen species (ROS) levels and/or the levels
of pro-inflammatory mediators, may be carried out in vitro [68]. Nanomaterial biodistribution and
clearance, which are mainly affected by opsonization and MPS activation/inhibition, need to be carried
out in vivo [69].
4.3. Multi-Arm Copolymers for Drug Delivery
Several studies reported the use of multi-arm star block copolymers for the encapsulation and release
of chemotherapeutic agents in mice and rats. One kind of multi-arm topology is achieved by generating the
copolymer from the H40 (Boltorn-type) dendrimeric polyester [70–74]. The ring-opening polymerization of
ε-caprolactone (CL) from the periphery of H40 and subsequent ATRP of oligo(ethylene glycol) monomethyl
ether methacrylate (OEGMA) and 3-azidopropyl methacrylate (AzPMA) was used to obtain well-defined
multi-arm star block copolymers, H40-PCL-b-P(OEGMA-co-AzPMA), which were conjugated by the click
reaction with the alkynyl-functionalized cancer cell-targeting moiety alkynyl-folate, and a T1-type
MRI contrast agent, alkynyl-DOTA–Gd (DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakisacetic
acid), affording H40-PCL-b-P(OEGMA-Gd-FA) [70]. This polymer was capable of encapsulating
paclitaxel and provided positive contrast enhancement in MR imaging, revealing good nanocarrier
accumulation within rat liver and kidney, and relatively long blood circulation.
Different studies reported the use of acid-cleavable (due to the presence of acetal groups)
H40-PCL-PEG based micelles for intracellular drug release and enhanced cancer therapy [75], since the
tumor microenvironment usually has lower pH compared to normal tissues and blood [76]. Enhanced
intracellular drug release has also been obtained by H40-PCL-based redox responsive polymers,
which presented a redox-sensitive (disulfide) cross-linker for glutathione-mediated intracellular drug
delivery [77].
In another study, H40 was used to generate amphiphilic polylactide-poly(ethylene glycol) (PLA-PEG)
block copolymer arms. In order to achieve active neuroendocrine (NE) tumor targeting, octreotide (OCT),
a somatostatin analog, with a strong binding affinity to somatostatin receptors (SSTRs), was conjugated
to the PEG outer shell, to obtain the final polymer H40-PLA-PEG-OCH3/OCT [71]. The resulting
micelles were loaded with the histone deacetylase inhibitor thailandepsin-A (TDP-A). Tests on NE
cancer-bearing nude mice demonstrated that these nanomaterials provided superior anticancer activity
in comparison with other TDP-A formulations, and showed a significantly reduced systemic toxicity.
A similar H40-PLA-PEG polymer was functionalized with an aptamer (A10) that can specifically
recognize the extracellular domain of the prostate-specific membrane antigen (PSMA), abundantly
expressed on the surface of the prostate cancer (PCa) cells [73]. Doxorubicin (DOX) was physically
encapsulated into the hydrophobic core of these unimolecular micelles and the H40-PLA-PEG-Apt
exhibited a much higher level of DOX accumulation in the tumour tissue of tumour-bearing mice, with
respect to the non-targeted DOX-loaded H40-PLA-PEG micelles.
A dendritic amphiphilic block copolymer H40-poly(D,L-lactide)-block-D-α-tocopheryl
polyethylene glycol 1000 succinate (H40-PLA-b-TPGS) was synthesized and loaded with docetaxel
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(DTX) [72]. The antitumor effect of this system was confirmed in mice by xenograft tumour model
with intraperitoneally injected human breast carcinoma MCF-7 cells, and it was significantly superior
to those of the linear copolymers and the free drug.
β-cyclodextrin (CD) was also used as multivalent scaffold to build multi-arm block
copolymers of poly-lactic acid (PLA), poly-2-(dimethylamino)ethyl methacrylate (PDMAEMA) and
poly-oligo(2-ethyl-2-oxazoline)methacrylate (PEtOxMA) [78]. PDMAEMA, containing tertiary amines,
made the polymers pH responsive. As predicted by Particle Dynamic Simulations (DPD), block
copolymers formed unimolecular micelles in water solution, with an average size of 19 nm (DLS), and
no evidence of CMC (Nile Red assay). Unimolecular micelles were used to encapsulate imiquimod
(IMQ), an immunostimulatory hydrophobic drug (DL = 1.6 wt%); as expected, the drug release was
faster at acidic pH. Additionally, micelles were used to condense plasmid DNA through the cationic
amino groups of the PDMAEMA chains. Micelliplexes with the average diameter ranging from 150
to 400 nm, were efficiently formed and preliminarily tested in a mouse dendritic cell line as dual
functional drug and gene nanocarriers.
β-cyclodextrin was used as initiator to generate the 21-arm star-like triblock polymer
β-cyclodextrin-{poly(ε-caprolactone)-poly(2-aminoethyl methacrylate)-poly[poly(ethylene glycol)
methyl ether methacrylate]}21 [β-CD-(PCL-PAEMA-PPEGMA)21], by combining ROP with ATRP
techniques [79]. The resulting unimolecular micelles formed in aqueous solution were used as a
template for fabricating gold nanoparticles (AuNPs) with uniform size and for the encapsulation
of doxorubicin (DOX). Tests on mice bearing human hepatocellular carcinoma HepG2 tumours
demonstrated that these theranostic nanomaterials exhibited similar efficacy to free DOX and effective
CT imaging performance.
Rather than encapsulating the therapeutic molecule within the core of the micelles, another
drug delivery approach consists of incorporating the drug into the micelle via a covalent
bond. Doxorubicin was conjugated to β-cyclodextrin (CD)-based multi-arm amphiphilic random
copolymers [80], which consisted of hydrophilic poly-oligo(ethylene glycol) methyl ether methacrylate
and 3-(4-formylphenoxy) propyl acrylate repeating units; the last ones were further functionalized
with DOX, forming an acid-labile Schiff–base linkage (Figure 8) [81]. Polymers in aqueous solution
formed nanoparticles with Dh = 16 nm (DLS); the size did not change when the concentration was
lowered from 500 to 50 µg/mL, thus indicating the presence of stable unimolecular micelles (Figure 8a).
Micelles released the 20% of DOX over 50 h at pH 7.2, and the 50% at pH 5.0; this sustained release
would be beneficial to avoid undesired drug leaching and toxicity toward healthy tissues. Micelles
were internalized by HeLa cells and finally localized in the cytoplasm in the first 12 h. By increasing the
incubation time to 24 h, DOX was released by polymers and accumulated within the nuclei (Figure 8c).
A similar approach involved the use of Boltorn H40 rather than β-CD as macromolecular core.
H40-poly(L-glutamate-hydrazone-doxorubicin)-b-poly(ethylene glycol) (H40-P(LG-Hyd-DOX)-b-PEG)
was conjugated with cRGD peptide (for integrin targeting) and macrocyclic chelators (NOTA) for
64Cu-labeling and PET imaging [74]. DOX was covalently conjugated via hydrazone linkage onto the
hydrophobic segments of the amphiphilic block copolymer arms (i.e., PLG) to enable pH-controlled
drug release. In tumor-bearing mice, H40-DOX-cRGD-64Cu also exhibited a much higher level of
tumor accumulation than H40-DOX-64Cu, as measured by non-invasive PET imaging and confirmed
by biodistribution studies.
Positively charged carriers, such as polyamidoamine (PAMAM) dendrimers, have a concentration-
dependent cytotoxicity [82] and may non-specifically interact with biomolecules, possibly resulting
in aggregated structures that are easily recognized by the immune system [83]. Using PAMAM
dendrimers as scaffolds in more complex architectures, for example to generate multi-arm block
copolymers, can be an alternative strategy for generating unimolecular micelles, exploiting their ability
to transport drugs, while weakening their side effects.
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Generation 4 PAMAM (PAMAM-G4) was used as macroinitiator for the formation of PLA arms
followed by PEG conjugation and final grafting with the GE11 peptide, which targets epidermal growth
factor receptor (EGFR), i.e., a protein which is frequently overexpressed in triple negative breast cancer
(TNBC) tumors [84]. The polymer was also conjugated with the Cy5.5 fluorophore and the resulting
PAMAM-PLA-PEG-OCH3/Cy5.5/GE11 unimolecular micelles were used to encapsulate aminoflavone
(AF), a drug which exhibits strong growth inhibitory effects in TNBC cells. The nanoformulation
significantly inhibited orthotopic TNBC tumour growth in a xenograft mice model, compared to
treatments with AF-loaded, GE11-lacking (non-targeted) unimolecular micelles or free AF.
PAMAM dendrimer was also used to generate amphiphilic poly(δ-valerolactone)-poly(ethylene
glycol) (PVL-PEG) block copolymer arms [85]. They were further conjugated with KE108 peptide
or octreotide (OCT), i.e., somatostatin analogs that display strong binding affinities to edullary
thyroid cancer (MTC) cells, and Cy5 dye. The histone deacetylase inhibitor AB3, which can effectively
inhibit MTC cell proliferation, was successfully encapsulated by these polymers. These AB3-loaded,
KE108-conjugated micelles demonstrated the best anticancer efficacy in mice without any apparent
systemic toxicity. The same polymer system (PAMAM–PVL–PEG–KE108/Cy5) was used for the
encapsulation of thailandepsin- (TDP-A), a recently discovered histone deacetylase (HDAC)
inhibitor [28]. In neuroendocrine (NE)-tumour-bearing nude mice, this nanoformulation showed
enhanced tumour accumulation due to its passive and active targeting capabilities and evident
anticancer efficacy without detectable syste ic toxicity.
An analogous PAM M (generation 4) derivative, connected to a PVL-PEG copolymer and
functionalized with the cholera toxin B domain (CTB), was used to target and protect retinal ganglion
cells (RGC), commonly lost in the glaucoma disease [86]. Unimolecular micelles with an average Dh
of 62 nm in aqueous solution were loaded with the neurosteroid dehydroepiandrosterone (DHEA,
DL = 18.6 wt%), which is known to have a protective role on retinal neurons. The drug was quickly
released under acidic conditions (pH 5.3), probably because of the fast degradation of the polyester
shell; a sustained release for at least two months was observed, which is a critical parameter to increase
long-term drug efficacy against chronic pathologies. In vivo assays based on intravitreal injection of
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loaded unimolecular micelles were carried out in mice with induced RCG degeneration. Targeted
micelles accumulated at the mouse RCG layer, contrarily to non-targeted ones. The therapeutic effect
of DHEA-targeted unimolecular micelles in preserving RCG cells was supported by their stability
in vivo, especially considering the high dilution and clearance in the eye environment.
PAMAM-PVL-PEG unimolecular micelles were also embedded in a synthetic biocompatible
hydrogel to encapsulate rapamycin and obtain prolonged steady drug release [87]. The perivascular
application of this hybrid system in rats produced a pronounced inhibitory effect on intimal
hyperplasia, thus exhibiting a real potential for mitigating restenosis after open surgery.
Biodegradable dendritic block copolymer poly(amidoamine)-polyglutamic acid-b-poly(ethylene
glycol) (PAM-PGlu-b-PEG), which was obtained from generation 3 PAMAM (PAMAM-G3) as a
core, was used to encapsulate and release the antitumour agent 1,2-diaminocyclohexane-platinum(II)
(DACHPt) for enhanced therapy of lung cancer [88]. The system demonstrated efficient antitumor
efficacy in mice on a xenograft tumour model with negligible tissue cytotoxicity.
Nanocarriers bearing fluorescent moieties act as theranostic devices, being both imaging and
drug delivery systems. A library of multi-arm polymers based on a pi-conjugated poly(fluorene-alt-
(4,7-bis(hexylthien)-2,1,3-benzothiadiazole)) (PFTB) backbone, with intrinsic strong FR/NIR
fluorescence, formed stable and fluorescent unimolecular micelles in aqueous solution [89]. PFTB was
connected to linear poly(ε-caprolactone) and comb-like poly-oligo(ethylene glycol) methyl ether
methacrylate chains, yielding PFTB-g-(PCL-b-POEGMA) copolymers. Their DOX-loaded unimolecular
micelles were internalized by both L929 and HeLa cells, and their high fluorescence allowed their
detection in the cytoplasmic and perinuclear regions.
The fluorescent perylene-3,4,9,10-tetracarboxylic acid diimide (perylene diimide, PDI) was
used as initiator to generate a novel PDI-core star block copolymer poly(D,L-lactide)-b-poly(ethyl
ethylene phosphate), named as PDI-star-(PLA-b-PEEP)8 [90]. The resulting unimolecular micelles
self-assembled into fluorescent supramolecular micelles (FSMs) with controllable sizes in aqueous
solution, and the potent hydrophobic anticancer drug camptothecin (CPT) was chosen as model
drug for nanoencapsulation. Tumour growth-inhibitory studies in MDA-MB-231 tumor-bearing mice
revealed a better therapeutic effect of FSMs after CPT encapsulation when compared with free CPT.
Redox-responsive star-shaped micelles were obtained from four-arm poly(ε-caprolactone)-
poly(ethylene glycol) copolymer [91]. The star-PCL polymer was synthesized by ROP of ε-caprolactone
(ε-CL) initiated by pentaerythritol. The redox-responsive behaviour was realized by connecting the
PCL and PEG segments with disulfide bonds. The PEG end groups were decorated with folate
(FA) to obtain active targeting, while DOX was trapped into the micelles during their self-assembly.
These micelles were specifically internalized into tumour cells through folate receptor-mediated
endocytosis, the disulfide bonds were immediately cleaved in response to the high level of glutathione,
and in turn DOX was released. An in vivo antitumor effect was evaluated in BALB/c mice bearing 4T1
tumour model, where these DOX@star-PECLss-FA micelles showed the best efficacy when compared
with those of free DOX, untargeted micelles, and redox-insensitive micelles.
4.4. Other Hyperbranched Copolymers
Poly(2-hydroxyethyl methacrylate) (PHEMA) was used as macromolecular initiator to generate
poly(L-lactide)-poly(ethylene glycol) (PLLA-PEG) as side chains, thus obtaining a brush-shaped
amphiphilic block copolymer, which was further conjugated with a monoclonal antibody against
CD105 (i.e., TRC105), a macrocyclic chelator for 64Cu-labeling, and finally loaded with doxorubicin to
generate multifunctional theranostic unimolecular micelles [92]. The DOX-loaded micelles showed a
pH-dependent drug release profile and a uniform size distribution. Noninvasive PET imaging were
carried out in 4T1 murine breast tumour-bearing mice, and a higher level of tumour accumulation was
demonstrated for 64Cu-labeled targeted micelles when compared with the nontargeted ones.
Paclitaxel was nanoencapsulated into unimolecular micelles based on hydrophobically derivatized
hyperbranched polyglycerols (dHPGs), for use as mucoadhesive intravesical agents against
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non-muscle-invasive bladder cancer [58]. Two different types of dHPGs (HPG-C10-polyethylene
glycol (PEG) and polyethyleneimine (PEI)-C18-HPG) were synthesized to obtain nanoparticles with
hydrodynamic radii of <10 nm, and incorporation of paclitaxel did not affect their size. When compared
with the PEI-C18-HPG formulation, HPG-C10-PEGs showed the best drug release profile and it was
also the only stable formulation in acidic urine. In vivo, nude mice with orthotopic KU7-luc tumors
were intravesically instilled with phosphate buffered saline, Taxol, or paclitaxel/HPG-C10-PEG.
The mucoadhesive HPG-C10-PEG formulation of paclitaxel was significantly more effective in reducing
orthotopic tumour growth than Taxol and was well tolerated.
A summary of drug-loaded unimolecular micelles, which were tested in vivo, are summarized in
Table 1.
Table 1. Unimolecular micellar systems used for in vivo drug delivery.
Polymer System PolymerArchitecture Drug Encapsulated Applications In Vivo Tests Reference
H40-PCL-b-
P(OEGMA-Gd-FA)
Multi-arm star block
copolymer Paclitaxel
Tumor therapy &
MRI contrast agent MR imaging in rats [70]
H40-PLA-PEG-OCT Multi-arm blockcopolymer Thailandepsin-A
Neuroendocrine
cancer therapy
Antitumor efficacy
in mice [71]
H40-PLA-b-TPGS Multi-arm blockcopolymer Docetaxel
Antitumor effect of
drug-loaded
nanoparticles
Antitumor activity
in mice [72]
H40-PLA-PEG-Apt
Aptamer-conjugated
multi-arm star block
copolymer
Doxorubicin Targeted therapy forprostate cancer
Higher level of
DOX found in mice
tumor tissue
[73]
H40-P(LG-Hyd-
DOX)-b-PEG-
OCH3/cRGD/NOTA
Multi-arm block
copolymer
conjugated with
cRGD and
macrocyclic chelator
Conjugated Doxorubicin
Cancer-targeted drug
delivery and
positron emission
tomography imaging
Higher level of
tumor
accumulation
in mice
[74]
β-CD-(PCL-
PAEMA-PPEGMA)21
21-arm star-like
triblock polymer Doxorubicin
Tumor therapy &
(CT) imaging
Antitumor efficacy
in mice [79]
PAMAM-PLA-PEG-
OCH3/Cy5.5/GE11
Multi-arm star block
copolymer Aminoflavone
Triple negative
breast cancer therapy
Antitumor efficacy
in mice [84]
PAMAM–PVL–
PEG–OCH3/Cy5/KE108
Multi-arm star block
copolymer AB3
Medullary thyroid
cancer therapy
Anticancer efficacy
in mice [85]
PAMAM–PVL–
PEG–OCH3/Cy5/KE108
Multi-arm star block
copolymer Thailandepsin-A
Neuroendocrine
cancer therapy
Antitumor efficacy
in mice [28]
PAMAM–PVL–
PEG–Cy5.5/CTB
Multi-arm block
copolymer
Dehydroepiandrosterone
(DHEA)
Therapy for loss of
retinal ganglion cells
(glaucoma)
Inhibitory effects
on RGC layer
degeneration
in mice
[86]
PAMAM–PVL–PEG Multi-arm blockcopolymer Rapamycin
Preventing
neointima-caused
(re)stenosis after
open surgery
Inhibitory effect on
intimal hyperplasia
in rats
[87]
PAM-PGlub-PEG Multi-arm blockcopolymer
1,2-diaminocyclohexane-
platinum(II) Lung cancer therapy
PK & Antitumor
efficacy in mice [88]
PDI-star-(PLA-b-PEEP)8
Core star block
copolymer Camptothecin
Fluorescence-guided
cancer therapy
Tumor
growth-inhibitory
effect in mice
[90]
star-PECLss-FA
Redox
responsive-four-arm
block copolymer
Doxorubicin Targeted anticancerdrug delivery
Antitumor effect
in mice [91]
PHEMA-PLLA-
PEG-TRC105
Brush-shaped block
copolymer Doxorubicin
pH-controlled
targeted drug
delivery and PET
Tumor uptake
in mice [92]
PEI-C18-HPG and
HPG-C10-PEG
Derivatized
hyperbranched
polyglycerols
Paclitaxel Intravesical bladdercancer therapy
Tumor growth
inhibition in mice [58]
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5. Conclusions
Properly designed amphiphilic copolymers, once dispersed in aqueous solution, can form
unimolecular micelles, i.e., single molecular architectures characterized by a hydrophobic core and a
stabilizing hydrophilic shell. Compared to conventional micelles, which are thermodynamic aggregates
of amphiphiles above their CMC, unimolecular micelles are stable to many environmental changes,
such as dilution and temperature. These are important advantages with regards to their potential
applications as drug delivery systems administered in vivo. In this review, recent advances on
complex polymeric structures, which are able to generate unimolecular micelles as a drug delivery
system, has been discussed. Generally, complex and hindered polymeric structures, characterized
by highly branched and strongly hydrophilic chains, yield unimolecular micelles with enhanced
stability. A strong emphasis has been put on analytical techniques, such as DLS, TEM, and CMC
determination, which can be used to unambiguously assess the formation of unimolecular micelles, and
discriminate them from multimolecular aggregates. In the last section, recent examples of unimolecular
micelles, used to encapsulate and release hydrophobic drugs to treat several pathologies, have been
presented. Their drug loading and release performances, as well as their activity in both in vitro
and in vivo conditions, were analyzed, highlighting how their thermodynamic stability results in
important features for biological applications, such as long blood circulation, undesired drug leaching
and reduced systemic toxicity.
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